| 1 | MAEU276710042 | 18 PACKAGES 2205 CARTONS PHARMACEUTICALS AS UNDER FLUTICASONE PROP NS 50MCG 120MD NDC CODE68462091820 FDA XXXXXXXXXXXX 63 B C Q 25 H.T. S NO.3004.32.0080 ANDA NO.219232 THERAPEU TICE USE NASAL STEROID TO TREAT NASAL SYMPTOMS SUCH AS CONGESTION SNEEZING ITCHING AND RUNNY NOSE CAUSED BY ALLERGIES (SEASONAL OR PERE, NNIAL) AND NONALLERGIC RHINITIS. FLUTICASONEPROP NS 50MCG 120MD NDC CODE68462091820 FDA XXXXXXXXXXXX 63 B C Q 25 H. T. S NO.3004.32.0080 ANDA NO.219232 THERAPEUTICE USE NASAL STEROID TO TREAT NASAL SYMPTOMS SUCH AS CONGESTION SNEEZING ITCHING AND RUNNY NOSE CAUSED BY ALLERGIES (SEASONAL OR PERENNIAL) AND NONALLERGIC RHINITIS. FLUTICASONE PROP NS 50MCG 120MD NDC CODE68462091820 FDA XXXXXXXXXXXX 63 B C Q 25 H. T. S NO.3004.32.0080 ANDA NO.219232THERAPEUTICE USE NASAL STEROID TO TREAT NASA L SYMPTOMS SUCH AS CONGESTION SNEEZING ITCHING AND RUNNY NOSE CAUSED BY ALLERGIES (SEASONAL OR PERENNIAL) AND NONALLERGIC RHINITIS. COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT.16.09.2026 F22700001763 DT. 16.09.2026 F22700001764 DT. 16.09.2026 SBILL NO 6892122 DT 16SEP2026 SBILL NO 6892133 DT 16SEP2026 SBILL NO 6892125 DT 16SEP2026 GROSS WT.8647.200 KGSNET WT.6456.240 KGS 18 DATA LOGGERS SET T EMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 DEGREES NOTIFY PARTY2 XXXXXXXX | GLENMARK PHARMACEUTICALS INC. USA | GLENMARK PHARMACEUTICALS LIMITED | 13 oct. 2026 | India | 8,665 kg | 18 PKG |
| 2 | MAEU276716517 | 46 PACKAGES 2947 CARTONS PHARMACEUTICALS AS UNDER ONDANSETRON ODT 4MG 30UD NDC CODE68462015713 FDA XXXXXXXXXXXX NO61 T C A 26 H. T. S NO. 3004.90.92.40 ANDA NO.78152 THERAPEUTICE USEANTI EMETIC GABAPENTIN TAB 600MG 500 NDCCODE68462012605 FDA XXXXXXXXXXXXXX 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.77662 THERAPE, UTICE USEANTICONVULSANT NAPROXEN TAB 500MG 100 NDC CODE68462019001 FDA XXXXXXXXXXXX NO.62G C A 49 H. T. S NO. 3004.90.92.40 ANDA NO.7 8250 THERAPEUTICE USEANTIINFLAMMATORY ANALGESIC NAPROXEN TAB 500MG 500 NDC CODE68462019005 FDA XXXXXXXXXXXX NO.62 G C A 49 H. T. S NO.3004.90.92.40 ANDA NO.78250 THERAPEUTICE USE ANTIINFLAMMATORY ANALGESIC COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT. 17.09.2026 F22752002530 DT. 17.09.2026 SBILL NO 6917573 DT 17SEP2026 SBILL NO 6918016 DT 17SEP2026 GROSS WT.9992.313 KGS NET WT.8073.756 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 DEGREES NOTIFY PARTY2 XXXXXXXXXXXXXXXXXXXXXXXXXXX0 USA | GLENMARK PHARMACEUTICALS INC. USA | GLENMARK PHARMACEUTICALS LIMITED | 13 oct. 2026 | India | 10,013 kg | 46 PKG |
| 3 | MAEU276716513 | 44 PACKAGES 2512 CARTONS PHARMACEUTICALS AS UNDER NAPROXEN TAB 500MG 100 NDC CODE68462019001 FDA XXXXXXXXXXXX NO.62 G C A 49 H. T. S NO. 3004.90.92.40 ANDA NO.78250 THERAPEUTICE USEANTIINFLAMMATORY ANALGESIC NAPROXEN TAB 500MG 500 NDC CODE68462019005 FDA XXXXXXXXXXXX NO.62 G C A 49 H. T. S NO. 3004.90.92.40 ANDA, NO.78250 THERAPEUTICE USEANTIINFLAMMATORY AN ALGESIC ONDANSETRON ODT 4MG 30UD NDC CODE68462015713 FDA XXXXXXXXXXXX NO61 T C A 26 H. T.S NO. 3004.90.92.40 ANDA NO.78152 THERAPEUTI CE USEANTI EMETIC MUPIROCIN OINT 2 22GM NDC CODE68462018022 FDA XXXXXXXXXXXX NO. 61 G J J81 H. T. S NO. 3004.90.92.45 ANDA NO. 90480 THERAPEUTICE USE ANTIBACTERIAL COMMERCIALCUSTOM INVOICE NO. XXXXXXXXXXXX DT. 15.09.2026 F22752002515 DT. 15.09.2026 F22752002516 DT. 15.09.2026 SBILL NO 6874514 DT 16SEP2026 SBILL NO 6875302 DT 16SEP2026 SBILL NO 6874505 DT 16SEP2026 GROSS WT.8237.370 KGS NET WT.6231.320 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE XXXXXXXXXXX | GLENMARK PHARMACEUTICALS INC. USA | GLENMARK PHARMACEUTICALS LIMITED | 13 oct. 2026 | India | 8,255 kg | 44 PKG |
| 4 | MAEU275928130 | PART OF FCL 24 PACKAGES 1879 CARTONS PHARMACEUTICALS AS UNDER GABAPENTIN TAB 600MG 500 NDC CODE68462012605 FDA XXXXXXXXXXXXXX 61 N CA 69 HTS NO.3004.90.9236 ANDA NO.77662 THERA PEUTICE USEANTICONVULSANT BISOPROLOLHCTZ TAB56.25MG 100 NDC CODE68462087901 FDA XXXXXXXXXNO.215995 THERAPEUTICE USEBISOPROLOL FUMARATE, AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATE D IN THE MANAGEMENT OF HYPERTENSION. TACROLIMUS CAP 5MG 100 NDC CODE68462068701 HTS NO 3004.90.92.15 FDA CODE 64 T C E 08 ANDA NO.206662 THERAPEUTICE USE TO PREVENT REJECTION OF A KIDNEY HEART OR LIVER TRANSPLANT BISOPROLOLHCTZ TAB 2.56.25MG 100 NDC CODE68462087801 FDA XXXXXXXXXXXX NO 62 O D A 18 HTS NO.3004.49.0010 ANDA NO.215995 THERAPEUTICE USEBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENSION. SAXAGLIPTIN TAB 5MG 30 NDC CODE68462072730 FDA XXXXXXXXXXXX NO.61 P C A 99 H. T. S NO.3004.90.9220 ANDA NO.205994 THERAPEUTICE USE ANTIDIABETIC AGENT CARVEDILOL TAB 25MG 100 NDC CODE68462016501 FDA XXXXXXXXXXXX NO 62 OC A 22 HTS NO.3004.90.9221 ANDA NO.78251 THERAPEUTICE USEBETA ADRENOACEPTOR ANTAGONIST COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT.30.08.2026 F22787000809 DT. 30.08.2026 F2278 7000823 DT. 31.08.2026 F22787000830 DT. 31.08.2026 F22787000832 DT. 31.08.2026 GROSS WT.6443.724 KGS NET WT.4850.791 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 DEGREES SBILL NO 6466890 DT01SEP26 SBILL NO 6466799 DT01SEP26 SBILL NO 6467037 DT01SEP26 SBILL NO 6466886 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX | GLENMARK PHARMACEUTICALS INC. USA | GLENMARK PHARMACEUTICALS LIMITED | 7 oct. 2026 | Oman | 6,457 kg | 24 PKG |
| 5 | MAEU276659778 | PART OF FCL 7 PACKAGES 853 CARTONS PHARMACEUTICALS AS UNDER CETIRIZINE HCL TAB 10MG 14(FT) NDC CODE70677127901 FDA XXXXXXXXXXXX 61 X A A 45 H. T. S NO. 3004.90.9280 ANDA NO. 0 78427 THERAPEUTICE USE ANTIHISTAMINE CETIRIZINE HCL TAB 10MG 30 (FT) NDC CODE70677127902 FDA XXXXXXXXXXXX 61 X A A 45 H. T. S NO. 3004, .90.9280 ANDA NO. 078427 THERAPEUTICE USE ANTIHISTAMINE CETIRIZINE HCL TAB 10MG 90 (FT) NDC CODE70677127904 FDA XXXXXXXXXXXX 61 X A A 45 H. T. S NO. 3004.90.9280 ANDA NO. 078427 THERAPEUTICE USE ANTIHISTAMINE CETIRIZINE HCLTAB 10MG 365 NDC CODE72657012935 FDA XXXXXXXXO. 78427 THERAPEUTICE USE. ANTIHISTAMINE COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT.30.08.2026 GROSS WT.1057.498 KGS NET WT.481.850 KGS 00 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX | GLENMARK PHARMACEUTICALS INC. USA | GLENMARK PHARMACEUTICALS LIMITED | 7 oct. 2026 | Oman | 1,060 kg | 7 PKG |
| 6 | MAEU276502250 | PART OF FCL 6 PACKAGES 288 CARTONS PHARMACEUTICALS AS UNDER APREPITANT CAP 40MG 5UD NDC CODE68462058385 FDA XXXXXXXXXXXX NO. 61 T C E32 H. T. S NO. 3004.90.92.40 ANDA NO.207777 THERAPEUTICE USEAPREPITANT IS USED WITH OTHERMEDICATIONS TO HELP PREVENT NAUSEA AND VOMIT ING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHE, RAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSEA AND VOMITING AFTER SURGERY. AEMETICNAUSEANT HUMAN RXSINGLE INGREDIENT DELAYED RELEASE TABLETS APREPITANT NITROGLYCERIN SUBLING TAB 0.6MG 100 NDC CODE68462064001 FDA PRODUCT CODE NO.66 S C A 28 H. T. S NO. 3004.90.9020 ANDA NO.206391 THERAPEUTICE USE MEDICATION USED FOR HEART FAILUREHIGH BLOOD PRESSUREAND TO TREAT AND PREVENT CHEST PAIN FROM NOTENOUGH BLOOD FLOW TO THE HEART APREPITANT C AP 40MG 1UD NDC CODE68462058340 FDA PRODUCT CODE NO. 61 T C E 32 H. T. S NO. 3004.90.92.40ANDA NO. 207777 THERAPEUTICE USE APREPITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVENT NAUSEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSEA AND VOMITING AFTERSURGERY. AEMETICNAUSEANT HUMAN RXSINGLE IN GREDIENT DELAYED RELEASE TABLETS APREPITANTAPREPITANT CAP 125MG 6UD NDC CODE6846205857 6 NDC NO.68462058576 FDA XXXXXXXXXXXX NO. 61 T C E 32 H. T. S NO. 3004.90.92.40 ANDA NO.207777 THERAPEUTICE USEAPREPITANT IS USED WITHOTHER MEDICATIONS TO HELP PREVENT NAUSEA ANDVOMITING CAUSED BY CANCER DRUG TREATMENT (CH EMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSEA AND VOMITING AFTER SURGERY. AEMETICNAUSEANT HUMAN RXSINGLE INGREDIENT DELAYED RELEASE TABLETS APREPITANT COMMERCIALCUSTOM INVOICE NO. XXXXXXXXXXXX DT. 30.08.2 026 F22787000811 DT. 30.08.2026 F22787000820 DT. 31.08.2026 F22787000822 DT. 31.08.2026 GROSS WT.749.476 KGS NET WT.376.970 KGS SBILLNO 6467017 DT01SEP26 SBILL NO 6466847 DT01SE P26 SBILL NO 6466832 DT01SEP26 SBILL NO 6466838 DT01SEP26 06 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15DEGREES TO 25 DEGREES NOTIFY PARTY2 XXXXXXXXX | GLENMARK PHARMACEUTICALS INC. USA | GLENMARK PHARMACEUTICALS LIMITED | 7 oct. 2026 | Oman | 751 kg | 6 PKG |
| 7 | MAEU275928125 | 44 PACKAGES 1843 CARTONS PHARMACEUTICALS AS UNDER ATOVAQUONEPROG TAB 250100MG 100 NDC CODE68462040401 FDA XXXXXXXXXXXX NO. 62 L D A 44H. T. S NO. 3004.90.92.90 ANDA NO. 91211 THE RAPEUTICE USE ANTI MALARIAL OMEPRAZOLE DR CAP 20MG 1000 NDC CODE68462039610 FDA XXXXXXXX1672 THERAPEUTICE USE TREATMENT OF TREAT GAST, ROESOPHAGEAL REFLUX DISEASE HEATHER TAB 0.35MG 84 NDC CODE68462030329 FDA XXXXXXXXXXXX NO. 65 J C A 24 H. T. S NO. 3006.60.00.00 ANDA NO.90454 THERAPEUTICE USE PREVENTION OF PREGNANCY. COMMERCIAL CUSTOM INVOICE NO. XXXXXXX02306 DT. 28.08.2026 F22752002310 DT. 29.08.2026 SBILL NO 6388038 DT 29AUG2026 SBILL NO 6388038 DT 29AUG2026 GROSS WT.7332.333 KGS NETWT.5857.538 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE XXXXX | GLENMARK PHARMACEUTICALS INC. USA | GLENMARK PHARMACEUTICALS LIMITED | 7 oct. 2026 | Oman | 7,348 kg | 44 PKG |
| 8 | MAEU275928136 | 47 PACKAGES 2602 CARTONS PHARMACEUTICALS AS UNDER OMEPRAZOLE DR CAP 20MG 1000 NDC CODE68462039610 FDA XXXXXXXXXXXX NO.62KCF10 HTS NO.3004.90.9255 ANDA NO.91672 THERAPEUTICE USE TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE LEVOCETIRIZINE DIHY TAB 5MG 90 NDC CODE68462034690 FDA XXXXXXXXXXXX NO. 61 X C A 51 H, . T. S NO. 3004.90.91.80 ANDA NO.90385 THERAPEUTICE USE TREATMENT OF CHRONIC IDIOPATHIC URTICARIA GABAPENTIN TAB 600MG 500 NDC CODE68462012605 FDA XXXXXXXXXXXXXX 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.77662 THERAPEUTICE USEANTICONVULSANT ATOVAQUONEPROG TAB 250100MG 100 NDC CODE68462040401 FDA XXXXXXXXXXXX NO. 62 L D A 44 H. T. S NO. 3004.90.92.90 ANDA NO. 91211 THERAPEUTICE USE ANTI MALARIAL GABAPENTIN TAB 600MG 500 NDC CODE68462012605 FDA XXXXXXXXXXXXXX 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.77662 THERAPEUTICE USEANTICONVULSANT NAPROXEN TAB 500MG 500 NDC CODE68462019005 FDA XXXXXXXXXXXX NO.62 G C A 49 H. T. S NO.3004.90.92.40 ANDA NO.78250 THERAPEUTICE USE ANTIINFLAMMATORY ANALGESIC CLOTRIMAZOLE CREAM 1 30GM NDC CODE68462018135 FDA XXXXXXXXXXXXNO 61 W C J 04 HTS NO.3004.90.9240 ANDA NO.9 0219 THERAPEUTICE USETREATMENT OF CANDIDIASISCOMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT. 31.08.2026 F22752002319 DT. 30.08.2026 F 22752002334 DT. 30.08.2026 F22752002335 DT. 30.08.2026 F22752002331 DT. 30.08.2026 SBILL NO 6430861 DT 31AUG2026 SBILL NO 6430853 DT 31AUG2026 SBILL NO 6435313 DT 31AUG2026 SBILL NO 6437221 DT 31AUG2026 SBILL NO 6428884 DT 31AUG2026 GROSS WT.12903.360 KGS NET WT.11226.660 KGS 02 DATA LOGGERS SET TEMPERATURE 18 DEGREES TEMPERATURE XXXXXXXXXXXXXXXXXXXXXXX | GLENMARK PHARMACEUTICALS INC. USA | GLENMARK PHARMACEUTICALS LIMITED | 7 oct. 2026 | Oman | 12,930 kg | 47 PKG |
| 9 | MAEU275928103 | 41 PACKAGES 1979 CARTONS PHARMACEUTICALS AS UNDER HEATHER TAB 0.35MG 84 NDC CODE68462030329 FDA XXXXXXXXXXXX NO. 65 J C A 24 H. T. S NO. 3006.60.00.00 ANDA NO.90454 THERAPEUTICE USE PREVENTION OF PREGNANCY. DROSPIRENONEEE TAB 30.02MG 84 NDC CODE68462072029 FDA XXXXXXX00 ANDA NO. 204296 THERAPEUTICE USE ORAL CON, TRACEPTIVE COMMERCIAL CUSTOM INVOICE NO. F22752002338 DT. 31.08.2026 F22752002342 DT. 31.08.2026 SBILL NO 6428907 DT 31AUG2026 SBILL NO 6428909 DT 31AUG2026 GROSS WT.5488.430 KGS NET WT.3906.820 KGS 02 DATA LOGGERS HUMIDITY65 SET XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX | GLENMARK PHARMACEUTICALS INC. USA | GLENMARK PHARMACEUTICALS LIMITED | 7 oct. 2026 | Oman | 5,500 kg | 41 PKG |
| 10 | MAEU275928094 | 46 PACKAGES 4680 CARTONS PHARMACEUTICALS AS UNDER CARVEDILOL TAB 3.125MG 500 NDC CODE68462016205 FDA XXXXXXXXXXXX NO 62 O C A 22 HTS NO.3004.90.9221 ANDA NO.78251 THERAPEUTICE USEBETA ADRENOACEPTOR ANTAGONIST OMEPRAZOLE DR CAP 40MG 1000 NDC CODE68462039710 FDA XXXXXXX91672 THERAPEUTICE USE TREATMENT OF TREAT GAS, TROESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 25MG 60 NDC CODE68462010860 FDA XXXXXXXXXXXX NO.61 M C A 40 H. T. S NO. 3004.49.00.20 ANDANO. 77627 THERAPEUTICE USEANTICONVULSANT TO PIRAMATE TAB 25MG 1000 NDC CODE68462010810 FDA XXXXXXXXXXXX NO.61 M C A 40 H. T. S NO. 3004.49.00.20 ANDA NO. 77627 THERAPEUTICE USEANTICONVULSANT TOPIRAMATE TAB 25MG 500 NDC CODE68462010805 FDA XXXXXXXXXXXX NO. 61 M C A 40 H. T. S NO. 3004.49.00.20 ANDA NO.077627 THERAPEUTICE USE ANTICONVULSANT TOPIRAMATE TAB 50MG 500 NDC CODE68462015305 FDA XXXXXXXXXXXX NO. 61 M C A 40 H. T. S NO. 3004.49.00.20 ANDA NO.077627 THERAPEUTICE USE ANTICONVULSANT NAPROXEN TAB 500MG 500 NDC CODE68462019005 FDA XXXXXXXXXXXX NO.62 G C A 49 H. T. S NO. 300XXXXXXXXXX ANDA NO.78250 THERAPEUTICE USEANTIINFLAMMATORY ANALGESIC LITHIUM CARB ER TAB 300MG 100 NDC CODE68462022301 FDA XXXXXXXXXXXXNO. 61 N C B 37 H. T. S NO. 3004.49.00.20 AN DA NO.91544 THERAPEUTICE USE INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER. BIPOLAR DISORDER MANIC (DSMIV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS MANIC IN THE OLDER DSMII TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISORDER. MAINTENANCE THERAPY REDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH MAY OCCUR. TOPIRAMATE TAB 50MG 1000 NDC CODE68462015310 FDA XXXXXXXXXXXX NO.61M C A 40 H. T. S NO. 3004.49.00.20 ANDA NO.77627 THERAPEUTICE USEANTICONVULSANT COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT. 31.08.2026 F22752002371 DT. 31.08.2026 F22752002369 DT. 31.08.2026 F22752002383 DT. 31.08.2026F22752002385 DT. 31.08.2026 F22752002387 DT. 31.08.2026 SBILL NO 6465098 DT 01SEP2026 SBI LL NO 6465095 DT 01SEP2026 SBILL NO 6465101 DT 01SEP2026 SBILL NO 6465107 DT 01SEP2026 SBILL NO 6465096 DT 01SEP2026 SBILL NO 6465106 DT 01SEP2026 GROSS WT.11588.881KGS NET WT.9489.546 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE XXXXXXXXXXXX | GLENMARK PHARMACEUTICALS INC. USA | GLENMARK PHARMACEUTICALS LIMITED | 7 oct. 2026 | Oman | 11,613 kg | 46 PKG |
'%3e%3ccircle%20r='20'%20fill='%23008'/%3e%3ccircle%20r='17.5'%20fill='%23fff'/%3e%3ccircle%20r='3.5'%20fill='%23008'/%3e%3cg%20id='d'%3e%3cg%20id='c'%3e%3cg%20id='b'%3e%3cg%20id='a'%20fill='%23008'%3e%3ccircle%20r='.875'%20transform='rotate(7.5%20-8.75%20133.5)'/%3e%3cpath%20d='M0%2017.5L.6%207%200%202l-.6%205L0%2017.5z'/%3e%3c/g%3e%3cuse%20height='100%25'%20width='100%25'%20xlink:href='%23a'%20transform='rotate(15)'/%3e%3c/g%3e%3cuse%20height='100%25'%20width='100%25'%20xlink:href='%23b'%20transform='rotate(30)'/%3e%3c/g%3e%3cuse%20height='100%25'%20width='100%25'%20xlink:href='%23c'%20transform='rotate(60)'/%3e%3c/g%3e%3cuse%20height='100%25'%20width='100%25'%20xlink:href='%23d'%20transform='rotate(120)'/%3e%3cuse%20height='100%25'%20width='100%25'%20xlink:href='%23d'%20transform='rotate(-120)'/%3e%3c/g%3e%3c/svg%3e){kind=small}
'/%3e%3c/svg%3e){kind=small}
'%3e%3cpath%20fill='%23fff'%20d='M-20%200h720v480H-20z'/%3e%3cpath%20fill='%23df0000'%20d='M-20%200h720v240H-20z'/%3e%3cpath%20d='M146.05%2040.227c-33.243%207.622-57.944%2032.237-64.927%2065.701-9.488%2045.469%2020.124%2089.99%2065.687%2099.488-46.031%2013.125-93.59-13.332-106.594-58.932-12.996-45.6%2013.46-93.16%2059.063-106.162%2016.007-4.565%2030.745-4.594%2046.773-.095z'%20fill='%23fff'/%3e%3cpath%20fill='%23fff'%20d='M132.98%20109.953l4.894%2015.119-12.932-9.23-12.87%209.317%204.783-15.144-12.833-9.354%2015.876-.137%204.932-15.106%205.031%2015.069%2015.889.025zm17.559%2052.059l4.894%2015.119-12.932-9.23-12.87%209.317%204.783-15.143-12.833-9.355%2015.877-.137%204.931-15.106%205.032%2015.07%2015.888.024zm58.425-.375l4.894%2015.119-12.932-9.23-12.87%209.317%204.783-15.143-12.833-9.355%2015.877-.137%204.931-15.106%205.032%2015.07%2015.888.024zM226.392%20110l4.894%2015.118-12.932-9.23-12.87%209.317%204.783-15.143-12.833-9.354%2015.877-.137%204.932-15.106%205.03%2015.069%2015.89.025zm-46.256-34.256l4.894%2015.118-12.932-9.23-12.87%209.317%204.783-15.143-12.833-9.355%2015.876-.136%204.932-15.106%205.032%2015.068%2015.888.025z'/%3e%3c/g%3e%3c/svg%3e){kind=small}